AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Whittaker Corporation. (joint venture with Boehringer Ingelheim Group to produce cell cultures and sera) (Special Issue: Telecommunications in Belgium)

Business Memo from Belgium

| January 01, 1992 | COPYRIGHT 1992 Embassy of Belgium. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

The aerospace concern WHITTAKER CORPORATION formed a joint-venture with BOEHRINGER INGELHEIM, a German pharmaceutical and chemical company, to produce cell cultures and sera using the ...

Related articles from newspapers, magazines, journals, and more
BOEHRINGER INGELHEIM AND MERIAL TO BRING TO JAPAN METACAM.
News wire article from: AsiaPulse News April 7, 2003 700+ words
...PRNewswire-AsiaNet - Boehringer Ingelheim Shionogi Vetmedica Co...venture between Nippon Boehringer Ingelheim and Shionogi &...Japan METACAM(R), Boehringer Ingelheim's market leading Non...
Boehringer Ingelheim Pharmaceuticals Uses Linux NetworX Cluster to Aid in Drug...
Press release article from: PR Newswire April 2, 2002 700+ words
...Linux NetworX announced today that Boehringer Ingelheim Pharmaceuticals, Inc. is advancing...Ridgefield, Conn. laboratory of Boehringer Ingelheim Pharmaceuticals is using the cluster...Computational chemists and biologists at Boehringer Ingelheim Pharmaceuticals are also using the...
Boehringer Ingelheim Vetmedica, Inc. Wins Favorable Decision In U.S. Patent...
Press release article from: PR Newswire August 7, 2000 700+ words
...Aug. 7 /PRNewswire/ -- Boehringer Ingelheim Vetmedica, Inc. announced today...patent infringement suit brought by Boehringer Ingelheim against Schering-Plough. Boehringer Ingelheim alleged in its lawsuit that Schering...
Boehringer Ingelheim Pharmaceuticals, Inc. Partners with C3i to Deliver...
Press release article from: Business Wire November 18, 2002 700+ words
...awarded a contract by Boehringer Ingelheim Pharmaceuticals, Inc...strategy that will enable Boehringer Ingelheim Pharmaceuticals to...vision. Shelly Berkle, Boehringer Ingelheim Pharmaceuticals' Executive...
Boehringer Ingelheim Invests an Additional $10 Million In Cambridge Neuroscience
Press release article from: PR Newswire August 22, 1996 700+ words
...22 /PRNewswire/ -- Boehringer Ingelheim and Cambridge NeuroScience...today announced that Boehringer Ingelheim GmbH is expanding its...Cambridge NeuroScience and Boehringer Ingelheim announced the pivotal...
Boehringer Ingelheim links business processes with objectives using eRoom:...
Magazine article from: Pharmaceutical Processing March 1, 2003 700+ words
...Business Environment The Boehringer Ingelheim Group of companies, head...Founded in 1885, the Boehringer Ingelheim Group employs more than...network. The Challenge For Boehringer Ingelheim Pharmaceuticals, Inc...
Boehringer Ingelheim and Vion Restructure License Agreement for Promising...
Press release article from: PR Newswire December 6, 1999 700+ words
...Conn., Dec. 6 /PRNewswire/ -- Boehringer Ingelheim International GmbH and Vion Pharmaceuticals...of the restructured agreement, Boehringer Ingelheim will assume full managerial and...the previous agreement, Vion and Boehringer Ingelheim were to share all clinical costs...
Boehringer Ingelheim Plans to Expand U.S. Pharmaceutical Sites in Ridgefield...
Press release article from: PR Newswire September 24, 2003 700+ words
...Sept. 24 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI...further decisive step in the future of Boehringer Ingelheim in the United States and in the...Board of Managing Directors, Boehringer Ingelheim. "Boehringer Ingelheim Pharmaceuticals...
Boehringer Ingelheim in Multi-Year Collaboration With Sagres Discovery To...
Press release article from: PR Newswire January 7, 2003 700+ words
...Calif., Jan. 7 /PRNewswire/ -- Boehringer Ingelheim International GmbH and Sagres Discovery...technologies. Under the agreement, Boehringer Ingelheim will receive from Sagres exclusive...certain targets and will receive from Boehringer Ingelheim a significant up-front payment...
Boehringer Ingelheim Exercises Option in Therapeutic Antibody Collaboration...
Press release article from: PR Newswire November 18, 2003 700+ words
Boehringer Ingelheim and MorphoSys AG (Frankfurt...Segment) today announced that Boehringer Ingelheim has exercised its first option...develop a therapeutic antibody for Boehringer Ingelheim against an undisclosed target...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA